Turnstone Biologics (TSBX) News Today → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free TSBX Stock Alerts $2.72 +0.02 (+0.74%) (As of 12:29 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 18 at 1:59 AM | americanbankingnews.comHead-To-Head Survey: Turnstone Biologics (TSBX) versus The CompetitionMay 26, 2024 | uk.investing.comPiper Sandler reaffirms Overweight rating on Turnstone Biologics sharesMay 16, 2024 | markets.businessinsider.comLeerink Partners Reaffirms Their Hold Rating on Turnstone Biologics Corp. (TSBX)May 13, 2024 | investorplace.comTSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024May 13, 2024 | globenewswire.comTurnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsMay 11, 2024 | finance.yahoo.comTurnstone Biologics Corp. (TSBX)May 8, 2024 | globenewswire.comTurnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceApril 18, 2024 | uk.investing.comTurnstone Biologics announces board member resignationApril 16, 2024 | globenewswire.comTurnstone Biologics Appoints William Waddill to its Board of DirectorsApril 12, 2024 | marketbeat.comShort Interest in Turnstone Biologics Corp. (NASDAQ:TSBX) Expands By 42.9%Turnstone Biologics Corp. (NASDAQ:TSBX - Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 625,900 shares, a growth of 42.9% from the March 15th total of 438,000 shares. Based on an average daily volume of 181,300 shares, the short-interest ratio is currently 3.5 days. Approximately 4.7% of the company's shares are short sold.April 12, 2024 | seekingalpha.comTSBX Turnstone Biologics Corp.March 22, 2024 | investorplace.comTSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023March 21, 2024 | globenewswire.comTurnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsMarch 7, 2024 | marketbeat.comFmr LLC Buys Shares of 2,830,284 Turnstone Biologics Corp. (NASDAQ:TSBX)Fmr LLC bought a new stake in Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,830,284 shares of the company's stock, valued at approximately $11,1March 2, 2024 | finance.yahoo.comTurnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34%March 1, 2024 | marketbeat.comEventide Asset Management LLC Makes New $2.79 Million Investment in Turnstone Biologics Corp. (NASDAQ:TSBX)Eventide Asset Management LLC acquired a new position in shares of Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,317 shares of the company's stock, valued atFebruary 23, 2024 | benzinga.comTurnstone Biologics Stock (NASDAQ:TSBX), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 21, 2024 | globenewswire.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 20, 2024 | finance.yahoo.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 20, 2024 | globenewswire.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 1, 2024 | marketbeat.comTurnstone Biologics (NASDAQ:TSBX) Stock Price Down 9.6%Turnstone Biologics (NASDAQ:TSBX) Shares Down 9.6%January 23, 2024 | msn.comRUM, ENVB and GAME among mid-day moversJanuary 21, 2024 | finance.yahoo.comHere's Why Turnstone Biologics (NASDAQ:TSBX) Must Use Its Cash WiselyJanuary 3, 2024 | seekingalpha.comIPOs In 2023 Disappoint But 2024 Looks BrighterNovember 27, 2023 | finance.yahoo.comTurnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 19, 2023 | realmoney.thestreet.comTurnstone Biologics price target lowered to $15 from $18 at BofANovember 10, 2023 | msn.comTurnstone Biologics GAAP EPS of -$1.00November 10, 2023 | msn.comTurnstone Biologics GAAP EPS of $1.00November 9, 2023 | finance.yahoo.comTurnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNovember 5, 2023 | morningstar.comTurnstone Biologics Corp TSBXNovember 3, 2023 | finance.yahoo.comTurnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 28, 2023 | finance.yahoo.comTurnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingSeptember 4, 2023 | msn.comTurnstone Biologics GAAP EPS of -$7.56 misses by $6.82September 1, 2023 | finance.yahoo.comTurnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 28, 2023 | wsj.comTurnstone Biologics Corp.July 25, 2023 | money.usnews.comTurnstone Biologics CorpJuly 24, 2023 | finance.yahoo.comTurnstone Biologics Corp. Announces Pricing of Upsized Initial Public OfferingJuly 24, 2023 | investing.comTurnstone Biologics Corp (TSBX) Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Reclusive millionaire’s final warning about America (Ad)This crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now. Click here to learn how to prepare before it's too late. TSBX Media Mentions By Week TSBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSBX News Sentiment▼0.940.90▲Average Medical News Sentiment TSBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSBX Articles This Week▼20▲TSBX Articles Average Week Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Adaptimmune Therapeutics News Today Molecular Partners News Today Genfit News Today Metagenomi News Today Candel Therapeutics News Today Coherus BioSciences News Today Monte Rosa Therapeutics News Today Innate Pharma News Today Invivyd News Today Fennec Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSBX) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredAvoid These AI Stocks Like the Plague...Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh co...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.